Literature DB >> 24747994

Diabetes, incretin hormones and cardioprotection.

A Myat1, S R Redwood1, B J Gersh2, D M Yellon3, M S Marber1.   

Abstract

Entities:  

Keywords:  MYOCARDIAL ISCHAEMIA AND INFARCTION (IHD)

Mesh：

Substances：

Year:  2014        PMID： 24747994     DOI： 10.1136/heartjnl-2012-303242

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  4 in total

1.  Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial.

Authors:  R V Seimon; D Espinoza; N Finer; W P T James; U F Legler; W Coutinho; A M Sharma; L Van Gaal; A P Maggioni; A Sweeting; C Torp-Pedersen; V Gebski; I D Caterson
Journal:  Int J Obes (Lond)       Date:  2014-12-18       Impact factor: 5.095

2.  Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study.

Authors:  Aung Myat; Satpal Arri; Deepak L Bhatt; Bernard J Gersh; Simon R Redwood; Michael S Marber
Journal:  Cardiovasc Diabetol       Date:  2015-02-19       Impact factor: 9.951

Review 3.  Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.

Authors:  Cecilia C Low Wang; Connie N Hess; William R Hiatt; Allison B Goldfine
Journal:  Circulation       Date:  2016-06-14       Impact factor: 29.690

Review 4.  Glucagon-Like Peptide-1: A Promising Agent for Cardioprotection During Myocardial Ischemia.

Authors:  Joel P Giblett; Sophie J Clarke; David P Dutka; Stephen P Hoole
Journal:  JACC Basic Transl Sci       Date:  2016-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.